Neuronetics Inc (STIM): Next-Year EPS Estimate 27.01%
As of 2026-06-04, Neuronetics Inc (STIM) has a next-year EPS growth estimate of 27.01%.
On 2026-05-13, analyst consensus for STIM's next-year EPS growth shifted from 33.53% to 27.01% — a negative change of 6.52 percentage points. The revised estimate has been sustained across 17 subsequent trading sessions. Current-year growth is projected at 21.52%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 27.01%
- EPS growth this year
- 21.52%
- EPS next quarter (est)
- -$0.12
- Last price
- $1.46
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 27.01% | 21.52% | -$0.12 | $1.46 |
| 2026-06-03 | 27.01% | 21.52% | -$0.12 | $1.39 |
| 2026-06-02 | 27.01% | 21.52% | -$0.12 | $1.56 |
| 2026-06-01 | 27.01% | 21.52% | -$0.12 | $1.67 |
| 2026-05-31 | 27.01% | 21.52% | -$0.12 | $1.54 |
| 2026-05-28 | 27.01% | 21.52% | -$0.12 | $1.54 |
| 2026-05-27 | 27.01% | 21.52% | -$0.12 | $1.22 |
| 2026-05-26 | 27.01% | 21.52% | -$0.12 | $1.22 |
| 2026-05-25 | 27.01% | 21.52% | -$0.12 | $1.20 |
| 2026-05-24 | 27.01% | 21.52% | -$0.12 | $1.20 |
| 2026-05-21 | 27.01% | 21.52% | -$0.12 | $1.19 |
| 2026-05-20 | 27.01% | 21.52% | -$0.12 | $1.19 |
| 2026-05-19 | 27.01% | 21.52% | -$0.12 | $1.18 |
| 2026-05-18 | 27.01% | 21.52% | -$0.12 | $1.18 |
| 2026-05-17 | 27.01% | 21.52% | -$0.12 | $1.28 |
| 2026-05-14 | 27.01% | 21.52% | -$0.12 | $1.30 |
| 2026-05-13 | 27.01% | 21.52% | -$0.12 | $1.50 |
| 2026-05-12 | 33.53% | 22.80% | -$0.12 | $1.27 |
| 2026-05-11 | 33.53% | 22.80% | -$0.12 | $1.50 |
| 2026-05-10 | 33.53% | 22.80% | -$0.12 | $1.65 |
| 2026-05-07 | 33.53% | 22.80% | -$0.12 | $1.84 |
| 2026-05-06 | 33.53% | 22.80% | -$0.12 | $1.91 |
| 2026-05-05 | 32.10% | 21.11% | -$0.12 | $2.17 |
| 2026-05-04 | 32.82% | 19.41% | -$0.17 | $2.02 |
| 2026-05-03 | 32.82% | 19.41% | -$0.17 | $2.02 |
| 2026-04-30 | 32.82% | 19.41% | -$0.17 | $1.94 |
| 2026-04-29 | 32.82% | 19.41% | -$0.17 | $1.70 |
| 2026-04-28 | 32.82% | 19.41% | -$0.17 | $1.64 |
| 2026-04-27 | 32.82% | 19.41% | -$0.17 | $1.69 |
| 2026-04-26 | 32.82% | 19.41% | -$0.17 | $1.68 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Neuronetics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Neuronetics Inc (STIM) has a next-year EPS growth estimate of 27.01%, based on analyst consensus.
When was the latest EPS estimate revision for STIM?▾
The most recent revision occurred on 2026-05-13, when analysts adjusted the next-year EPS growth estimate from 33.53% to 27.01%.
What sector and industry does Neuronetics Inc belong to?▾
Neuronetics Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. STIM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Neuronetics Inc (STIM) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports